Indianapolis, IN, United States of America

Marvin M Hoehn


Average Co-Inventor Count = 2.4

ph-index = 9

Forward Citations = 202(Granted Patents)


Company Filing History:


Years Active: 1976-1993

Loading Chart...
34 patents (USPTO):Explore Patents

Title: Marvin M. Hoehn: A Pioneer in Antibiotic Research and Development

Introduction: Marvin M. Hoehn, based in Indianapolis, Indiana, is a prominent inventor known for his significant contributions to the field of antibiotic research. With an impressive portfolio of 34 patents, he has established himself as a key player in the development of novel antibiotics and pest control methods.

Latest Patents: Hoehn's recent patents highlight his innovative approaches to combating bacterial infections and rodent populations. One of his notable inventions is the patent for A59770 antibiotics, which introduces a novel antibiotic complex. These compounds are particularly useful as pesticides, specifically as rodenticides. The patent also details methods for reducing rodent populations and includes a rodenticidal composition derived from the A59770-producing Amycolatopsis orientalis culture. Another groundbreaking patent involves the A54145 antibiotics, where Hoehn provides new peptide antibiotic components that serve as effective antibacterial agents. This invention not only focuses on combatting infections but also improves growth performance in animals, especially in poultry. He has detailed methods for producing the A54145 antibiotic from biologically pure cultures of Streptomyces fradiae.

Career Highlights: As a distinguished inventor, Hoehn has dedicated much of his career to Eli Lilly and Company, where he has worked alongside other notable individuals in the field. His innovative spirit has driven his work in creating effective solutions for health and safety.

Collaborations: Throughout his career, Marvin M. Hoehn has collaborated with esteemed colleagues, including Robert L. Hamill and Karl H. Michel. These collaborations have further advanced research initiatives and innovations within the pharmaceutical industry.

Conclusion: Marvin M. Hoehn's contributions to antibiotic development have made a lasting impact on both human health and agriculture. His inventive work at Eli Lilly and Company continues to pave the way for new solutions to combat pressing challenges in healthcare and pest management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…